What is Cardiff Lexingto's earnings per share (EPS)?

Cardiff Lexingto (CDIXD) reported diluted earnings per share of -$0.98 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cardiff Lexingto (CDIXD) Financials

CDIXD

Trailing 12 months to March 31, 2026

Revenue $10.8M +22.3% YoY

Net Income -$8.1M -134.8% YoY

EPS (Diluted) -$0.98 FY2025 annual

Operating Cash Flow -$2.4M -7.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CDIXD SEC filings page.

Cardiff Lexingto (CDIXD) reported $10.8M in revenue over the twelve months to Mar 31, 2026, up 22.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CDIXD FY2025 2026-08-30

Operating recovery was overwhelmed by interest-heavy financing, leaving the business profitable at the operating line but cash-negative overall.

The FY2025 rebound in operating income did not reach shareholders: interest expense rose to $6.8M while net income was -$5.5M. Cash conversion also remained weak; operating cash flow was -$2.9M despite revenue of $11.5M, showing that improved accounting performance was not yet becoming internally generated cash.

Gross margin moved from 53.6% in FY2024 to 62.5% in FY2025. Operating margin also moved from -2.3% to 9.5%, pointing to improved gross economics plus better absorption of operating costs rather than growth alone explaining the recovery.

The balance sheet shifted toward creditor financing: long-term debt reached $18.6M as equity turned negative, while the current ratio slipped to 0.9x. Separately, accounts receivable reached $22.1M against $11.5M of FY2025 revenue, a working-capital pattern that helps explain why sales growth has not produced positive operating cash flow.

Financial Health Signals

Financial health score not available

Cardiff Lexingto does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Weak

3/9

Cardiff Lexingto passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Cardiff Lexingto reported a net loss of $5.5M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.16x

Cardiff Lexingto earns $0.16 in operating income for every $1 of interest expense ($1.1M vs $6.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.2M

YoY-23.8%

QoQ-19.8%

5Y CAGR+19.0%

10Y CAGR+23.3%

Cardiff Lexingto generated $2.2M in revenue in Q1 2026. This represents a decrease of 23.8% from the same quarter a year earlier. Against the prior quarter it is down 19.8%.

EBITDA

-$511K

YoY-193.3%

QoQ+26.6%

Cardiff Lexingto's EBITDA was -$511K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 193.3% from the same quarter a year earlier. Against the prior quarter it is up 26.6%.

Net Income

-$3.1M

YoY-585.9%

QoQ-15.1%

Cardiff Lexingto reported -$3.1M in net income in Q1 2026. This represents a decrease of 585.9% from the same quarter a year earlier. Against the prior quarter it is down 15.1%.

EPS (Diluted)

-$0.23

Cardiff Lexingto earned -$0.23 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Cash & Debt

$684K

YoY-31.4%

QoQ+114.6%

5Y CAGR+6.0%

10Y CAGR+27.8%

Cardiff Lexingto held $684K in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

15M

QoQ+10.6%

5Y CAGR-32.7%

10Y CAGR+4.3%

Cardiff Lexingto had 15M shares outstanding in Q1 2026. Against the prior quarter it is up 10.6%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

59.3%

YoY-3.8pp

QoQ-4.2pp

5Y change+12.1pp

10Y change+9.4pp

Cardiff Lexingto's gross margin was 59.3% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.

Operating Margin

-23.0%

YoY-41.7pp

QoQ+2.1pp

5Y change+17.3pp

10Y change+48.1pp

Cardiff Lexingto's operating margin was -23.0% in Q1 2026, reflecting core business profitability. This is down 41.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.

Return on Equity

-79.8%

YoY-57.6pp

Cardiff Lexingto's ROE was -79.8% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 57.6 percentage points from the same quarter a year earlier.

Net Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

None of these metrics is reported for Q1 2026.

CDIXD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CDIXD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$10.8M	$11.5M+39.5%	$8.3M-30.2%	$11.9M+10.8%	$10.7M+8.2%	$9.9M+186.1%	$3.5M-6.9%	$3.7M+66.5%	$2.2M+37.0%	$1.6M+41.3%	$1.2M-17.2%	$1.4M+56.1%	$890K	$0-100.0%	$839+220.2%	$262
Cost of Revenue	$4.2M	$4.3M+12.7%	$3.8M+7.9%	$3.6M-12.3%	$4.1M+7.7%	$3.8M+125.9%	$1.7M+0.2%	$1.7M+13.2%	$1.5M+2.7%	$1.4M+79.6%	$797K-20.1%	$998K+52.6%	$654K	$0	N/A	$0
Gross Profit	$6.7M	$7.2M+62.7%	$4.4M-46.6%	$8.3M+25.0%	$6.6M+8.6%	$6.1M+242.3%	$1.8M-12.6%	$2.0M+170.1%	$756K+289.9%	$194K-45.1%	$353K-9.9%	$392K+65.7%	$237K	$0	N/A	$262
SG&A Expenses	$5.2M	$5.3M+31.2%	$4.1M+32.1%	$3.1M+13.8%	$2.7M-39.0%	$4.4M+23.6%	$3.6M+8.5%	$3.3M+20.0%	$2.8M+34.1%	$2.1M-18.2%	$2.5M	N/A	N/A	N/A	N/A	N/A
Operating Income	$45K	$1.1M+668.8%	-$194K-103.7%	$5.2M+33.0%	$3.9M+135.1%	$1.7M+192.1%	-$1.8M-41.9%	-$1.3M+37.1%	-$2.0M+32.5%	-$3.0M-38.2%	-$2.2M+44.6%	-$3.9M	N/A	N/A	N/A	N/A
EBITDA	N/A	$1.1M+714.4%	-$180K-103.5%	$5.2M+32.7%	$3.9M+134.5%	$1.7M+194.1%	-$1.8M-48.0%	-$1.2M+38.0%	-$1.9M+29.8%	-$2.8M-38.9%	-$2.0M+48.0%	-$3.8M	N/A	N/A	N/A	N/A
Interest Expense	$7.7M	$6.8M+124.0%	$3.0M+592.8%	$440K-2.9%	$453K	N/A	$144K-70.6%	$489K+48.7%	$329K+194.6%	$112K+128.9%	$49K+52.0%	$32K-47.5%	$61K	N/A	N/A	N/A
Income Tax	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$8.1M	-$5.5M-66.7%	-$3.3M-209.1%	$3.0M+155.8%	-$5.4M-914.9%	$666K+123.5%	-$2.8M+60.5%	-$7.2M-14.6%	-$6.3M-71.6%	-$3.7M-62.0%	-$2.3M+42.8%	-$3.9M	N/A	N/A	N/A	N/A
EPS (Basic)	N/A	-$0.98+10.1%	-$1.09-100.7%	$155.66+115.6%	-$999.00-9989900.0%	-$0.01+99.8%	-$4.98+98.2%	-$282.66	N/A	N/A	-$0.17+67.3%	-$0.52+95.4%	-$11.39+98.0%	-$582.78-5827900.0%	$0.01+120.0%	-$0.05
EPS (Diluted)	—	-$0.98	-$1.09	$149.88	-$999.00	-$0.01	-$4.98	-$282.66	N/A	N/A	N/A	-$0.52	-$11.39	-$582.78	$0.01+120.0%	-$0.05
Diluted Shares (Avg)	N/A	8M	4M	15,001	5,822	128M	908,485	25,401	N/A	N/A	N/A	8M	1M	18,845	75M+38.1%	54M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Revenue	$2.2M-23.8%	$2.8M-11.2%	$3.1M+125.6%	$2.8M+89.5%	$2.9M+25.6%	$3.1M+31.3%	$1.4M-60.2%	$1.5M-56.3%
Cost of Revenue	$904K-15.9%	$1.0M-8.0%	$1.1M+14.8%	$1.1M+37.9%	$1.1M+13.4%	$1.1M+13.2%	$1.0M+81.5%	$793K-26.7%
Gross Profit	$1.3M-28.4%	$1.8M-12.9%	$1.9M+437.8%	$1.7M+149.8%	$1.8M+34.0%	$2.0M+43.8%	$355K-87.6%	$679K-70.3%
SG&A Expenses	$1.2M-9.1%	$1.8M+27.7%	$1.2M+30.7%	$987K+18.3%	$1.3M+50.4%	$1.4M+46.8%	$937K+62.2%	$835K+57.5%
Operating Income	-$511K-194.0%	-$696K-309.6%	$643K+209.9%	$610K+482.3%	$544K+148.4%	$332K-19.9%	-$585K-125.7%	-$159K-109.1%
EBITDA	-$511K-193.3%	-$696K-307.3%	$644K+210.7%	$610K+491.0%	$547K+146.1%	$336K-20.9%	-$582K-125.6%	-$156K-108.9%
Interest Expense	$1.9M+92.4%	$2.2M+47.5%	$1.8M+27.4%	$1.8M+4340.6%	$993K+824.2%	$1.5M+304.8%	$1.4M+513.0%	$41K-95.1%
Net Income	-$3.1M-585.9%	-$2.7M-195.1%	-$1.1M+42.1%	-$1.2M-832.0%	-$451K-59.2%	-$910K-468.9%	-$2.0M-199.8%	-$132K-116.1%
EPS (Basic)	-$0.23-64.3%	N/A	-$0.07+56.3%	-$0.08-100.0%	-$0.14-27.3%	N/A	-$0.16-100.1%	-$0.04-100.1%
EPS (Diluted)	-$0.23	N/A	-$0.07+56.3%	-$0.08	-$0.14-27.3%	N/A	-$0.16	-$0.04
Diluted Shares (Avg)	15M	N/A	20M+40.4%	19M	5M+33.7%	N/A	14M	13M

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

CDIXD Balance Sheet

CDIXD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$29.1M+21.6%	$23.9M+15.3%	$20.7M+55.5%	$13.3M-12.8%	$15.3M+210.3%	$4.9M+0.3%	$4.9M+47.5%	$3.3M+152.7%	$1.3M-46.6%	$2.5M+103.9%	$1.2M-3.1%	$1.3M+17936.9%	$7K+62.6%	$4K-90.7%	$46K
Current Assets	$22.6M+31.3%	$17.2M+21.4%	$14.2M+107.6%	$6.8M+3.6%	$6.6M+2129.5%	$296K+58.4%	$187K-32.7%	$277K+45.4%	$191K+9.4%	$174K+230.9%	$53K-30.2%	$75K+1090.5%	$6K+80.4%	$4K-66.7%	$11K
Cash & Equivalents	$319K-73.2%	$1.2M+37.1%	$867K+295.7%	$219K-62.3%	$581K+108.0%	$279K+177.2%	$101K-36.5%	$159K-23.7%	$208K+230.3%	$63K-12.1%	$72K+54.6%	$46K+890.4%	$5K+152.5%	$2K-79.1%	$9K
Short-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$3K0.0%	$3K-93.4%	$47K+11.1%	$42K	$0	N/A	N/A	N/A	N/A
Accounts Receivable	$22.1M+38.5%	$15.9M+19.8%	$13.3M+101.5%	$6.6M+9.9%	$6.0M+36575.8%	$16K-83.5%	$100K+54.7%	$64K+2.0%	$63K+97.0%	$32K+59174.1%	$54-98.6%	$4K	$0	N/A	N/A
Long-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M-27.0%	$7.8M	N/A	$3.5M+67.3%	$2.1M	$0-100.0%	$933K	$0	N/A	$0	N/A	N/A
Total Liabilities	$26.0M+22.5%	$21.2M+6.1%	$20.0M+32.6%	$15.1M+1.9%	$14.8M+7.3%	$13.8M+18.6%	$11.6M+42.3%	$8.2M+72.2%	$4.7M+16.7%	$4.1M+123.3%	$1.8M+29.3%	$1.4M-22.4%	$1.8M-62.3%	$4.8M-41.5%	$8.2M
Current Liabilities	$25.8M+62.6%	$15.9M+14.6%	$13.9M+39.1%	$10.0M-10.8%	$11.2M-16.6%	$13.4M+24.7%	$10.7M+50.5%	$7.1M+50.3%	$4.7M+16.7%	$4.1M+123.3%	$1.8M+39.2%	$1.3M-24.8%	$1.7M-61.7%	$4.5M-43.6%	$8.1M
Non-Current Liabilities	$182K-96.6%	$5.4M-13.0%	$6.2M+20.1%	$5.1M+1833.7%	$265K-33.7%	$400K-55.3%	$895K-14.0%	$1.0M	$0	$0	$0-100.0%	$100K+33.5%	$75K-71.5%	$263K+66.1%	$158K
Long-Term Debt	$18.6M+101.5%	$9.2M+303.8%	$2.3M+1365.8%	$156K-74.1%	$601K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$106K+157.6%	$41K
Total Equity	-$2.5M-192.0%	$2.7M+267.1%	$731K+141.9%	-$1.7M-458.4%	$487K+105.5%	-$8.9M-31.9%	-$6.7M-38.8%	-$4.8M-41.3%	-$3.4M-114.5%	-$1.6M-162.0%	-$610K-284.7%	-$159K+91.2%	-$1.8M+62.4%	-$4.8M+41.2%	-$8.2M
Retained Earnings	-$79.5M-9.0%	-$72.9M-6.2%	-$68.7M+3.2%	-$70.9M-8.9%	-$65.1M+0.7%	-$65.6M-4.8%	-$62.6M-13.0%	-$55.4M-12.8%	-$49.1M-8.0%	-$45.5M-5.2%	-$43.2M-10.0%	-$39.3M-50.3%	-$26.1M-72.5%	-$15.1M+3.8%	-$15.7M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Total Assets	$30.3M+19.6%	$29.1M+21.6%	$27.6M+17.4%	$26.5M+7.3%	$25.3M+12.1%	$23.9M+15.3%	$23.5M+27.0%	$24.7M+53.9%
Current Assets	$23.9M+28.2%	$22.6M+31.3%	$21.0M+25.6%	$19.9M+10.0%	$18.6M+17.0%	$17.2M+21.4%	$16.8M+39.2%	$18.1M+88.0%
Cash & Equivalents	$684K-31.4%	$319K-73.2%	$232K-88.1%	$560K-82.5%	$997K-20.5%	$1.2M+37.1%	$1.9M+975.8%	$3.2M+682.8%
Accounts Receivable	$22.9M+30.8%	$22.1M+38.5%	$20.7M+39.9%	$19.2M+29.2%	$17.5M+19.5%	$15.9M+19.8%	$14.8M+24.9%	$14.9M+61.6%
Goodwill	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%	$5.7M0.0%
Total Liabilities	$24.6M+35.1%	$26.0M+22.5%	$22.6M+14.2%	$20.5M+44.7%	$18.2M-14.8%	$21.2M+6.1%	$19.8M+10.9%	$14.2M-17.6%
Current Liabilities	$24.4M+36.1%	$25.8M+62.6%	$22.4M+52.9%	$20.3M+46.1%	$17.9M+19.3%	$15.9M+14.6%	$14.6M+23.1%	$13.9M+20.8%
Non-Current Liabilities	$272K-19.4%	$182K-96.6%	$215K-95.8%	$249K-20.1%	$337K-94.7%	$5.4M-13.0%	$5.1M-13.5%	$312K-94.6%
Long-Term Debt	N/A	$18.6M+101.5%	$15.1M+83.4%	$13.1M+77.9%	$10.7M+185.9%	$9.2M+303.8%	$8.2M+4753.3%	$7.4M+4252.2%
Total Equity	$3.9M+90.4%	-$2.5M-192.0%	-$364K-109.8%	$754K-87.2%	$2.0M+68.3%	$2.7M+267.1%	$3.7M+451.9%	$5.9M+596.7%
Retained Earnings	-$82.9M-12.5%	-$79.5M-9.0%	-$76.5M-6.6%	-$75.1M-8.0%	-$73.6M-6.5%	-$72.9M-6.2%	-$71.8M-4.5%	-$69.6M+1.3%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.

CDIXD Cash Flow Statement

CDIXD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$2.4M	-$2.9M-3.2%	-$2.8M-60.7%	-$1.7M-49.6%	-$1.2M-35.4%	-$850K+5.9%	-$903K+13.8%	-$1.0M+4.6%	-$1.1M-78.7%	-$615K-210.3%	-$198K-161.5%	-$76K+89.1%	-$697K	N/A	N/A	N/A
Depreciation & Amortization	N/A	$6K-58.0%	$13K-35.2%	$21K-10.2%	$23K+66.6%	$14K-39.9%	$23K-65.9%	$68K-14.6%	$79K-65.2%	$228K+30.4%	$175K+106.3%	$85K+111.9%	$40K+25701.3%	$155-99.0%	$16K+36.1%	$12K
Stock-Based Compensation	N/A	$754K+38.5%	$545K	$0	N/A	N/A	N/A	$0-100.0%	$287K+0.6%	$286K-72.0%	$1.0M-67.5%	$3.1M-73.2%	$11.7M+374.0%	$2.5M+1674.1%	$139K+510.1%	$23K
Capital Expenditures	N/A	N/A	N/A	N/A	$0-100.0%	$3K	$0	N/A	$852K	$0-100.0%	$19K-82.9%	$109K	$0	N/A	$0-100.0%	$43K
Free Cash Flow	N/A	N/A	N/A	N/A	-$1.2M-34.8%	-$854K+5.5%	-$903K	N/A	-$2.0M-217.3%	-$615K-183.6%	-$217K-17.0%	-$185K+73.4%	-$697K	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	$0+100.0%	-$2.3M	N/A	$32K+104.3%	-$760K-5838.7%	-$13K-198.7%	$13K	N/A	N/A	N/A	$0+100.0%	-$43K
Financing Cash Flow	$2.1M	$2.0M-33.3%	$3.0M+25.6%	$2.4M+200.4%	$789K-78.5%	$3.7M+219.6%	$1.2M+60.3%	$718K-60.3%	$1.8M+185.6%	$634K+259.0%	$177K	N/A	N/A	N/A	N/A	N/A
Dividends Paid	$0	$50K-50.0%	$100K-87.2%	$780K+131.7%	$337K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Operating Cash Flow	-$17K+96.6%	-$390K+46.0%	-$574K+36.7%	-$1.4M-1293.7%	-$491K+52.5%	-$723K+37.9%	-$908K-205.6%	-$100K-0.8%
Depreciation & Amortization	$593-82.4%	$762-77.4%	$762-77.4%	$763-77.3%	$3K0.0%	$3K-64.2%	$3K0.0%	$3K0.0%
Stock-Based Compensation	$664K	N/A	$41K	$98K	$0-100.0%	N/A	$0	$0
Financing Cash Flow	$382K+27.2%	$476K+1326.3%	$247K+172.7%	$961K-53.0%	$300K-77.1%	-$39K-102.1%	-$339K-589.2%	$2.0M+1064.1%
Dividends Paid	$0-100.0%	$0	$0	$0-100.0%	$50K	$0-100.0%	$0	$100K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.

CDIXD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CDIXD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	62.5%+8.9pp	53.5%-16.4pp	70.0%+7.9pp	62.0%+0.2pp	61.9%+10.2pp	51.7%-3.4pp	55.1%+21.1pp	33.9%+22.0pp	11.9%-18.8pp	30.7%+2.5pp	28.2%+1.6pp	26.6%	N/A	N/A	100.0%
Operating Margin	9.5%+11.9pp	-2.3%-46.2pp	43.8%+7.3pp	36.5%+19.7pp	16.8%+69.1pp	-52.3%-18.0pp	-34.3%+56.5pp	-90.8%	-184.1%	-188.2%	-281.4%	N/A	N/A	N/A	N/A
Net Margin	-47.7%-7.8pp	-39.9%-65.5pp	25.6%+76.3pp	-50.8%-57.5pp	6.7%+88.9pp	-82.2%	-193.7%	-281.3%	-224.6%	-196.0%	-283.8%	N/A	N/A	N/A	N/A
Return on Equity	N/A	-123.0%-537.0pp	414.0%	N/A	136.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-18.9%-5.1pp	-13.8%-28.4pp	14.6%+55.3pp	-40.7%-45.1pp	4.4%+61.9pp	-57.5%+88.5pp	-146.1%+41.9pp	-188.0%+88.9pp	-276.9%-185.7pp	-91.2%+234.1pp	-325.3%	N/A	N/A	N/A	N/A
Current Ratio	0.87-0.2x	1.08+0.1x	1.02+0.3x	0.69+0.1x	0.59+0.6x	0.020.0x	0.020.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.06+0.1x	0.000.0x	0.000.0x	0.00
Debt-to-Equity	N/A	3.43+0.3x	3.12	N/A	1.23	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.40+0.1x	0.35-0.2x	0.57-0.2x	0.80+0.2x	0.65-0.1x	0.70-0.1x	0.75+0.1x	0.67-0.6x	1.23+0.8x	0.47-0.7x	1.15+0.4x	0.71+0.7x	0.00-0.2x	0.20+0.2x	0.01
FCF Margin	N/A	N/A	N/A	-10.8%-2.1pp	-8.6%+17.5pp	-26.2%	N/A	-87.6%-49.8pp	-37.8%-19.0pp	-18.9%-5.5pp	-13.3%+64.9pp	-78.3%	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Gross Margin	59.3%-3.8pp	63.5%-1.2pp	62.4%+36.2pp	60.8%+14.7pp	63.1%+4.0pp	64.8%+5.6pp	26.2%-57.6pp	46.1%-21.7pp
Operating Margin	-23.0%-41.7pp	-25.1%-35.8pp	21.0%+64.2pp	21.9%+32.7pp	18.7%+9.2pp	10.6%-6.8pp	-43.2%-109.9pp	-10.8%-62.8pp
Net Margin	-139.1%	-96.9%-67.7pp	-37.4%	-44.0%-35.0pp	-15.5%-3.3pp	-29.2%-39.6pp	-145.9%	-8.9%-33.2pp
Return on Equity	-79.8%-57.6pp	N/A	N/A	-162.7%-160.5pp	-22.1%+1.3pp	-33.9%-67.6pp	-53.0%-346.3pp	-2.2%
Return on Assets	-10.2%-8.4pp	-9.2%-5.4pp	-4.1%+4.3pp	-4.6%-4.1pp	-1.8%-0.5pp	-3.8%-5.0pp	-8.4%-19.1pp	-0.5%-5.6pp
Current Ratio	0.98-0.1x	0.87-0.2x	0.94-0.2x	0.98-0.3x	1.040.0x	1.08+0.1x	1.14+0.1x	1.30+0.5x
Debt-to-Equity	6.35+1.1x	N/A	N/A	17.39+16.1x	5.26+2.2x	3.43+0.3x	2.20+2.0x	1.25
Asset Turnover	0.070.0x	0.100.0x	0.11+0.1x	0.110.0x	0.120.0x	0.130.0x	0.06-0.1x	0.06-0.2x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Note: Shareholder equity is negative (-$2.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where Cardiff Lexingto Ranks

Frequently Asked Questions

What is Cardiff Lexingto's annual revenue?

Cardiff Lexingto (CDIXD) reported $11.5M in total revenue for fiscal year 2025. This represents a 39.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cardiff Lexingto's revenue growing?

Cardiff Lexingto (CDIXD) revenue grew by 39.5% year-over-year, from $8.3M to $11.5M in fiscal year 2025.

Is Cardiff Lexingto profitable?

No, Cardiff Lexingto (CDIXD) reported a net income of -$5.5M in fiscal year 2025, with a net profit margin of -47.7%.

What is Cardiff Lexingto's EBITDA?

Cardiff Lexingto (CDIXD) had EBITDA of $1.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cardiff Lexingto have?

As of fiscal year 2025, Cardiff Lexingto (CDIXD) had $319K in cash and equivalents against $18.6M in long-term debt.

What is Cardiff Lexingto's gross margin?

Cardiff Lexingto (CDIXD) had a gross margin of 62.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cardiff Lexingto's operating margin?

Cardiff Lexingto (CDIXD) had an operating margin of 9.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cardiff Lexingto's net profit margin?

Cardiff Lexingto (CDIXD) had a net profit margin of -47.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cardiff Lexingto's operating cash flow?

Cardiff Lexingto (CDIXD) recorded an outflow of $2.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Cardiff Lexingto's total assets?

Cardiff Lexingto (CDIXD) had $29.1M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Cardiff Lexingto have outstanding?

Cardiff Lexingto (CDIXD) had 14M shares outstanding as of fiscal year 2025.

What is Cardiff Lexingto's current ratio?

Cardiff Lexingto (CDIXD) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Cardiff Lexingto's return on assets (ROA)?

Cardiff Lexingto (CDIXD) had a return on assets of -18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Cardiff Lexingto's debt-to-equity ratio negative or not reported?

Cardiff Lexingto (CDIXD) has negative shareholder equity of -$2.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Cardiff Lexingto's Piotroski F-Score?

Cardiff Lexingto (CDIXD) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cardiff Lexingto's earnings high quality?

Cardiff Lexingto (CDIXD) reported a net loss of $5.5M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cardiff Lexingto cover its interest payments?

Cardiff Lexingto (CDIXD) has an interest coverage ratio of 0.16x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.